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DIAGNOSTIC INTERVENTIONS IN 
NUCLEAR MEDICINE 
ABSTRACT.-Diagnostic interventions in nuclear medicine may be de- 
fined as the coadmhxistration of a nonradioactive drug or application 
of a physical stimulus or physiologic maneuver to enhance the diag- 
nostic utility of a nuclear medicine test. The rationale for each inter- 
ventional maneuver follows from the physiology or metabolism of the 
particular organ or organ system under evaluation. Diagnostic infer- 
ence is drawn from the pattern of change in the biodistribution of the 
tracer in response to the intervention-induced change in metabolism 
or function. 
In current practice, the most commonly performed interventional 
maneuvers are aimed at studies of the heart, genitourinary system, he- 
patobiliary system, and gastrointestinal tract. The single most com- 
monly performed interventional study in the United States is the stress 
Thallium-201 myocardkd perfusion scan aimed at the diagnosis of cor- 
onary artery disease. The stress portion of the study is accomplished 
with dynamic leg exercise on a treadmill and is aimed at increasing 
myocardial oxygen demands. Areas of myocardium distal to hemodyn- 
amically significant lesions in the coronary arteries become ischemic 
at peak stress due to the inability of the stenotic vessel to respond to 
the oxygen demand/blood flow needs of the myocardium. Ischemic 
areas are readily recognized as photopenic defects on scans obtained . 
immediately after exercise, with “normalization” upon delayed imag- 
ing. 
Diuresis renography is aimed at the differential diagnosis of hydro- 
ureteronephrosis. By challenging the urinary tract collecting struc- 
tures with an augmented urine flow, dilated, unobstructed systems can 
be differentiated from systems with significant mechanical obstruc- 
tion. Obstructed systems have a low ability to respond even after effec- 
tive diuresis, resulting in a characteristic prolonged retention of the 
radiotracer. 
Hepatobiliary interventions are most commonly employed in the 
clinical setting of suspected acute cholecystitis. Administering a chole- 
cystogogue before a hepatobiliary tracer promotes visualization of the 
gallbladder by causing it to go through a contraction/filling cycle in 
which the fillhtg phase occurs during maximum exposure to the radio- 
nuclide. This maneuver can convert a false positive study that suggests 
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the presence of acute cholecystitis to a true negative study. Other gas- 
trointestinal interventions are aimed at enhancing the detection of 
gastroesophageal reflux and gastrointestinal bleeding. 
Many new interventions have been developed that are currently 
aimed at research problems rather than clinical problems. Elegant 
studies eliciting cortical activation in response to visual, auditory, and 
cognitive stimulae have been described for the brain and show clinical 
promise for the future. New interventions are also under investigation 
for the heart and kidney. The development of new tracers and instru- 
mentation will continue to be paralleled by the development of new 
interventional maneuvers. 
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DIAGNOSTIC INTERVENTIONS IN 
NUCLEAR MEDICINE 
Over the past decade, interventional maneuvers 
have become an integral part of diagnostic nuclear 
medicine .le3 Within this context, interventions may 
be defined as the coadministration of a drug or the 
application of a physiological or physical stimulus 
to enhance or extend the diagnostic capability of a 
nuclear medicine examination. Although diagnos- 
tic interventions have only been used extensively 
in the last several years, they were applied early in 
the history of this specialty. Soon after the avail- 
ability of 1311 for medical use, it was recognized 
that the percent localization of the tracer in the 
thyroid was a useful marker of specific organ func- 
tion. The thyroid glands of hyperthyroid subjects 
demonstrated greater than normal accumulation; 
conversely, hypothyroid subjects typically had de- 
creased percent uptakes. By performing the ra- 
dioiodine percent uptake measurement in con- 
junction with interventional stimulation or 
suppression of the thyroid gland, additional useful 
information on thyroid autonomy and functional 
reserve, respectively, could be obtained. Such in- 
terventional maneuvers with 1311 were described 
and well established during the late 1940s and 
early 1950s. 
The early thyroid interventional studies have re- 
mained useful but have never represented a large 
portion of nuclear medicine practice. Although 
waterloading and mannitol infusion enjoyed brief 
vogues in renal studies aimed at detecting renal 
vascular hypertension, little was added to the in- 
terventional armamentarium during the 1950s and 
1960s. 
In the 1970s a number of developments encour- 
aged the growth and diversification of interven- 
tional techniques. Nuclear medicine computer 
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systems became widely available and permitted 
the quantitative analysis of radiotracer distribution 
and, of equal importance, dynamic function stud- 
ies of the time-activity distribution of radiotracers. 
This new analytic capability was coupled with the 
development of new radiopharmaceuticals and 
new applications of existing radiopharmaceuticals 
in virtually every organ system of the body. As a 
result, it is not uncommon to find that 25% to 50% 
of all studies in a full-seivice nuclear medicine de- 
partment involve an intelventional maneuver. 
The wide variety of interventional nuclear medi- 
cine procedures makes it difficult to provide a sim- 
ple classification. The essential purpose of an in- 
tervention is to alter organ function and gain 
diagnostic information, either by noting a change 
in the biodistribution of the radiopharmaceutical 
or by directly measuring a change in organ func- 
tion with a radiotracer technique.’ For example, 
the radioiodine percent uptake test is essentially a 
measurement of the relative biodistribution of ra- 
dioiodine at a fixed time within the thyroid gland. 
Diagnostic inference is achieved by obtaining a 
baseline measurement and noting whether a 
change occurs following the intervention, i.e., 
whether there is a change in the biodistribution. 
On the other hand, in a stress radionuclide ventri- 
culogram, the biodistribution of the radiopharma- 
ceutical does not change. The radiolabeled red 
blood cells remain within the vascular space, but 
changes in ventricular ejection fraction induced by 
the intervention are measured by using the radi- 
otracer. 
In addition to the use of interventions for the 
enhancement of nuclear diagnoses, an important 
correlate has also evolved: the assessment of drug 
9 
efficacy (or toxicity) by using radionuclide tech- 
niques. For example, in a patient with an estab- 
lished diagnosis of impaired left ventricular func- 
tion due to coronary artery disease, the benefits of 
cardiac drugs are readily determined by nuclear 
medicine assessments of ventricular function per- 
formed before and after drug administration. An- 
other example involves the administration of me- 
toclopramide to promote gastric emptying in 
diabetics with gastric paresis. Response to the 
drug is variable and requires some residual inner- 
vation of the stomach. The use of radionuclide 
techniques to directly measure the gastric empty- 
ing response after metoclopramide administration 
provides an objective rationale for administering or 
not administering the drug, an important consid- 
eration in view of its significant potential side ef- 
fects. 
From the preceding discussion, it becomes ap- 
parent that each interventional maneuver has a 
specific rationale that must be met if the interven- 
tion is to be meaningful. For pharmacological in- 
terventions, a dose of the drug must be deter- 
mined that will reliably achieve the desired or 
critical change in organ function. For example, if 
too little thyroid hormone is administered in de- 
termining thyroid autonomy, the test results will 
obviously be invalid. Dosage regimens have been 
established in the development of each pharma- 
cological intervention to reliably achieve the de- 
sired objective. Physiological and physical inter- 
ventions are more challenging in this respect, but 
in each case, criteria have been developed to per- 
mit assessment of the adequacy of the interven- 
tion. In cardiac stress testing, the heart rate and 
blood pressure response to exercise are measured 
as indicators of the work being performed by the 
heart and, therefore, the adequacy of the interven- 
tion. The development of better methods to inde- 
pendently determine whether the rationale for a 
specific interventional maneuver has been met 
continues to be a challenge. Likewise, to compare 
results between patients, protocols must be repro- 
ducible. For pharmacological interventions, this 
process is reasonably straightforward, but m 
interventions requiring patient involvement and 
compliance, reproducibility is more problem- 
atic. 
Literally dozens of interventional techniques 
have been described in the literature. This article 
will not attempt to summarize all of them but will 
emphasize primarily those procedures and tech- 
niques that have achieved widespread clinical ac- 
ceptance and are in routine daily use (Table 1). 
Some additional interventions will be described to 
illustrate developmental trends and the wealth of 
opportunity for future clinical studies. 
TABLE 1. 
Clinically Important Diagnostic Interventions 
Commonly performed interventions 
Heart.-Dynamic isotonic exercise [stress “IT1 myocardial 
perfusion imaging) 
Kidney.-Diuresis renography iktrosemideJ 
Bladder.-Direct cystography 
Hepatobiliary.-Gallbladder stimulation (cholecystogogues) 
Less commonly performed interventions 
Thyroid.-TSH stimulation, T, suppression 
Adrenal.-Dexamethasone suppression 
Heart.-Dynamic isotonic exercise (exercise ventriculography) 
Gastrointestinal-Gastroesophageal reflux, GI bleeding 
Abbreviations: TSH. thyroid-stimulating hormone; T,, triiodothyronine; GI, 
gastrointestinal. 
THYROID INTERVENTIONS 
As noted in the introduction, interventional 
studies of the thyroid gland were the first to be 
established in nuclear medicine practice. Werner 
and Spooner demonstrated that thyroidal uptake 
of iodine would suppress to less than 50% of base- 
line values after administration of thyroid hor- 
mone.4 Thyroid suppression testing became valu- 
able for distinguishing hyperthyroid from 
euthyroid patients in selected cases and for de- 
tecting patients with euthyroid Graves’ disease. 
The primary disadvantage of the suppression test 
is that it requires two radioiodine uptake measure- 
ments 1 week apart and the administration of ex- 
ogenous thyroid hormone to patients frequently 
already thyrotoxic.5 In current practice, the 
suppression test has given way to the thyrotropin- 
releasing hormone infusion test, which measures 
the thyroid-stimulating hormone response to thy- 
rotropin-releasing hormone administration. This 
test can be performed in an hour and requires no 
exposure of the patient to ionizing radiation or 
thyroid hormone.6’ 7 
The protocol most frequently used for the thy- 
roid suppression test includes a baseline 24-hour 
radioiodine uptake measurement followed by the 
administration of triiodothyronine, 25 pg four 
times a day for 8 days, followed by a second 24- 
hour radioiodine uptake test on the last day of the 
suppression regimen. Failure of the uptake to de- 
crease by more than 50% from baseline values is 
considered abnormal. 
The suppression test has also been adapted to 
the evaluation of functioning thyroid nodules to 
determine whether they are autonomous.8’s After a 
baseline scan, thyroid function is suppressed by 
using the triiodothyronine regimen outlined ear- 
lier with a follow-up scan obtained on the last day 
of the test. If the functioning nodule is the only 
portion of the thyroid visualized, autonomy or the 
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lack thereof can be established by the quantitative 
criteria cited for the suppression test. If both nod- 
ular and non-nodular activity are visualized, an as- 
sessment must be made of the relative suppressi- 
bility of the nodular activity in relation to the rest 
of the gland. If the extranodular tissue activity is 
clearly suppressed without change in uptake in 
the nodule, autonomous function is inferred. If 
nodular activity is suppressed to an equal degree 
and the overall uptake declines by more than 50%, 
the inference is that the nodule is not autono- 
mous. If multiple functioning nodules are present 
or the response is not clearly defined, it may be 
difficult to prove or disprove the autonomy of a 
given nodule. 
tients receiving repeat doses of thyroid-stimulating 
hormone.13 
Clinically, thyroid hormone therapy is often 
used to reduce the size of benign goiters and thy- 
roid nodules. If suppression testing reveals non- 
suppressibility, the nodule will probably not re- 
spond to thyroid hormone therapy and must be 
dealt with in some other manner. Although the tri- 
iodothyronine suppression test is usually well tol- 
erated, it is contraindicated in patients with heart 
disease. If their thyroid function is not suppressi- 
ble, the added exogenous hormone may result in 
cardiac toxicity, including tachyarrhythmias or an- 
gina. 
A third interventional technique involving the ra- 
dioiodine percent uptake procedure is the per- 
chlorate discharge test.14 This test measures the 
dissociation between trapping and organification 
of iodine in the thyroid gland. Radioiodine is ad- 
ministered to the patient, after which a baseline 
percent uptake measurement is taken at 1 to 2 
hours. One gram of potassium perchlorate is ad- 
ministered orally, and follow-up measurements 
are made hourly. In normal subjects and in hyper- 
thyroid patients receiving inadequate antithyroid 
drug therapy, there is less than a 10% decline in 
percent uptake from the baseline value. Dissocia- 
tion of trapping and organification is indicated by 
a decrease greater than 10%. Patients with Hashi- 
moto’s thyroiditis or peroxidase enzyme defi- 
ciency and patients receiving inadequate antithy- 
roid dw therapy for hyperthyroidism 
demonstrate this dissociation.15’ l6 
ADFUXNAJ., INTEXWENTIONS 
The thyroid-stimulating hormone stimulation 
test was originally used in conjunction with the 
radioiodine percent uptake test to measure thy- 
roid reserve. It has also been used in conjunction 
with imaging to diagnose congenital thyroid hem- 
iagenesis, to determine the extent of extranodular 
thyroid tissue in patients with autonomous func- 
tioning nodules, and to enhance tracer localization 
in follow-up scanning for metastatic disease after 
thyroid surgery for cancer.” 
In normal subjects and patients with hypopitui- 
tarism, the percent uptake ordinarily doubles af- 
ter 5 to 10 units of thyroid stimulating hormone 
are administered intramuscularly for 3 days.5 Pa- 
tients with primary hypothyroidism demonstrate 
diminished functional reserve. Diminished re- 
serve is also seen in some patients with non- 
toxic multinodular goiters and Hashimoto’s thy- 
roiditis . 
The advent of computed tomography (CT) 
shortly after the clinical introduction of radiola- 
beled cholesterol derivatives for adrenal cortical 
scintigraphy eroded much of the interest in the 
nuclear medicine technique. Clinically, it is impor- 
tant to determine whether the cause of excess 
adrenal hormone production is due to an adrenal 
adenoma or hyperplasia. If adenoma is present, 
the therapy is often unilateral adrenalectomy. If 
hyperplasia occurs, the therapy may be directed 
either at the pituitary, a paraendocrine source of 
stimulating hormone, or in cases of primary hy- 
perplasia at the adrenals themselves. If an ade- 
noma is detected by CT scanning, the workup may 
be complete; if not, adrenal scintigraphy may still 
play a role. 
The thyroid-stimulating hormone stimulation 
test is only used occasionally in current practice. 
The differentiation of primary and secondary hy- 
pothyroidism is now accomplished by the thyroid- 
releasing hormone-thyroid-stimulating hormone 
test. Moreover, there is some risk in administering 
thyroid-stimulating hormone since the clinically 
available agent is a bovine protein.11’12 Antigen-an- 
tibody reactions can occur, especially with re- 
peated studies.l” l3 In one series, allergic reactions 
of varying severity were observed in 43% of pa- 
For cortisol-producing lesions, the incorporation 
of dexamethasone suppression into the adrenal 
cortical scintigraphy procedure is not necessary 
because of the adrenal-pituitary feedback mecha- 
nisms. In cortisol-producing adenomas, the excess 
hormone suppresses pituitary adrenocorticotropic 
hormone (ACTHI release, and as a result, the con- 
tralateral normal adrenal does not accumulate the 
radiotracer.17’ *’ Scintigraphy reveals intense unilat- 
eral activity corresponding to the adenoma. In 
cases of bilateral hyperplasia, both adrenals are vi- 
sualized. 
In patients with hyperaldosteronism or hyper- 
androgenism, the excess hormone does not cause 
feedback suppression of pituitary ACTH release. It 
is therefore often difficult to distinguish adenoma 
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from hyperplasia without suppression testing (Fig 
1) .lSZ4 The suppression test involves the oral ad- 
ministration of dexamethasone, 4 mgday, in di- 
vided doses for 7 days prior to the administration 
of radiocholesterol. Dexamethasone administra- 
tion is continued throughout the imaging inter- 
vd220,22 With this interventional regimen, the nor- 
mal adrenal cortices should not be visualized until 
at least 5 days after radiotracer injection. The pres- 
ence of an aldosteronoma or androgenoma is in- 
dicated by unilateral or asymmetrical uptake on 
images obtained 1 or 2 days after tracer adminis- 
tration. In patients with bilateral hyperplasia, early 
(i.e., within 5 days after radiocholesterol adminis- 
tration) bilateral visualization is typically demon- 
strated.zz-24 The technique is reasonably accurate. 
Freitas et al. reported a series of 20 patients with 
hyperaldosteronism in whom the scintigraphic 
technique correctly located the site of nine of ten 
adenomas and distinguished adenoma from hy- 
perplasia in 90% of the cases.23 
RENAL INTERVENTIONS 
Two quite different renal interventions have be- 
come clinically important. Diuresis renography is 
aimed at the differential diagnosis of causes of 
pyelocaliceal and ureteral dilation, and radionu- 
elide cystography is aimed at detecting vesicoure- 
teral reflux. 
DIURESIS RENOGRAPHY 
The management of mechanical obstruction of 
the ureteropelvic junction or ureter is usually sur- 
gical, while medical management is often appro- 
priate for a dilated, but nonobstructed collecting 
system. Conventional urography with intravenous 
radiographic contrast media and conventional ra- 
dionuclide renography do not reliably differentiate 
cases of obstructive vs. nonobstructive hydroure- 
teronephrosis because the findings are not spe- 
cific. The dilation, delayed opacification, and de- 
layed washout typical of the obstructive 
conditions may also be seen in many other con- 
ditions that cause collecting system dilation but 
are not necessarily associated with mechanical ob- 
struction (Fig 2). 
In attempting to determine the significance of 
collecting system dilation two different ap- 
proaches have been developed to assess urodyn- 
amics. In 1973, Whittaker described a percuta- 
neous ureteral perfusion technique to measure 
pressure-flow relationships in the renal pelvis.25 A 
catheter or trocar is placed in the renal pelvis, and 
the bladder is catheterized. A baseline measure- 
ment of the pressures in the renal pelvis and blad- 
der is obtained, and pressures are continuously 
measured during perfusion of the renal pelvis with 
a dilute solution of a radiopaque contrast medium 
at the rate of 10 mUmin. If there is no obstruction 
in the collecting system, the differential pressure 
FIG 1. 
Radiocholesterol images in a patient with hyperaldosteronism. The top two images are the analog (left) and computer display (right) 
images obtained in the patient under basal conditions. The adrenals appear symmetrical (in this posterior view the activity in the upper 
right hand corner of the image is normal hepatic activity). The bottom two images are the corresponding analog and computer views in 
a repeat study after the patient had undergone dexamethasone suppression. The failure of the left adrenal activity to be suppressed and 
resultant significant asymmetry between the two glands indicate the presence of a left aldosteronoma. (From Thrall JH, Freitas JE, 
Beierwaltes WH: Adrenal scintigraphy. Semin Nucl Med 1978; 8:23341. Used with permission.) 
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FIG 2. 
Excretory urogram in a patient with intermittent left flank pain. The 
left renal pelvis and calices are mild to moderately dilated. There 
is the appearance of a narrowing at the left ureteropelvic junction. 
This case illustrates the usual clinical dilemma: is the collecting 
system mechanrcally obstructed, or is this a nonobstructed, dilated 
system? 
between kidney and bladder remains low, less 
than 10 to 12 cm H,O in normal individuals. In the 
presence of significant mechanical obstruction, the 
equilibrium pressure exceeds 15 cm H,O. The clin- 
ical value of the test has been attested by a num- 
ber of investigators.2”“0 The technique is contrain- 
dicated in cases of acute pyelonephritis or 
pyelonephrosis and should be used with caution 
in patients with bleeding disorders.“l 
In the alternative noninvasive radionuclide tech- 
nique, a diuretic is used to stimulate urine flow 
while the rate of clearance of the tracer from the 
collecting structures is measured. The rationale for 
the test comes from the observation that the mean 
transit time of a tracer through a system is equal 
to the ratio of the volume of the system divided by 
the rate of flow through the system (i.e., f = V/F). 
Thus, in a large dilated collecting system, there is 
a reservoir effect that results in the prolonged re- 
tention of a radiotracer or contrast material. Stim- 
ulating the flow of urine with a diuretic should re- 
duce the mean transit time of a radionuclide in 
dilated, but nonobstructed systems by increasing 
urine flow. On the other hand, in a system with a 
fixed mechanical obstruction, the system either 
cannot respond or will respond only minimally to 
the diuretic, and a failure of tracer washout or per- 
haps even a further increase in its accumulation in 
the collecting structures will be observed. 
Diuretic augmented urography was first de- 
scribed in the late 1960s.3” In 1978, O’Reilly et al. 
described qualitative response patterns for normal 
collecting systems, dilated nonobstructed systems, 
and obstructed systems using scintillation probes 
placed over the kidneys and 13*1-hippuran as the 
tracer.33’ 34 Koff and coworkers incorporated a 
gamma camera interfaced to a nuclear medicine 
computer system and introduced the use of ggmT~- 
diethylenetriamine-pentaacetic acid (DTPA) as the 
tracer.35-37 Gamma camera modification of the 
technique permitted region-of-interest analysis 
and extended the procedure to evaluation of the 
ureters as well as the ureteropelvic junction. The 
use of ““Tc-DTPA alforded a significant reduction 
in the radiation dose and sufficient photon flux for 
simultaneous imaging and quantitative washout 
analysis. 
The basic procedure protocol involves imaging 
the kidneys and their collecting structures before 
and after the administration of a potent, high-ceil- 
ing diuretic. In the approach of Koff and cowork- 
ers, the patient is studied in a normally hydrated 
condition.35’ 37 A wide-field-of-view gamma camera 
is used to permit imaging from the level of the kid- 
neys to the bladder, and the patient is imaged 
while in a sitting position in the posterior view. 
Infants and small children may be imaged supine 
or prone. An adult dose of 10 to 15 mCi of sgmT~- 
DTPA is used. By incorporating a nuclear medicine 
computer system, an initial flow study is obtained 
at one frame every z seconds to assess relative 
renal perfusion. After 3 minutes, frames are ac- 
quired every 30 to 60 secbnds (Fig 3,A and B). The 
relative uptake in the two kidneys from 1 to 2 min- 
utes provides a measure of differential glomerular 
filtration between the kidneys and is a useful ad- 
junctive parameter, particularly in assessing the 
response to therapy. This analysis requires regions 
of interest over each kidney and a summation of 
net activity from the appropriate frames of the flow 
study (Fig 3,C). 
The persistence scope of the gamma camera 
and/or the computer-acquired images are moni- 
tored to determine when the kidneys and collect- 
ing structures are completely visualized. When 
complete visualization has been confirmed, 0.3 to 
0.5 mgkg of furosemide is administered intrave- 
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FIG 3. 
A, posterior-view flow study obtained by using 15 mCi ggmT~-DTPA. Each image is for 2 seconds. Note the asymmetry of renal perfusion, 
with more activity appearing during the arterial phase on the left than on the right. B, regions of interest for the kidneys, aorta, and 
background areas with corresponding flow study time-activity histograms. The higher peak associated with the left kidney indicates 
greater perfusion. C, summation of the total counts in the l- to 2-minute interval indicates a 60% relative contribution from the left kidney 
and a 40% relative contribution from the right kidney-a significant difference in the glomerular filtration rate on the two sides, (From 
Thrall JH, Koff SA, Keyes JW Jr: Diuretic radionuclide urography in the differential diagnosis of hydroureteronephrosis. Semin Nucl Med 
1981; 11:89-i 14. Used by permission.) 
nously. Slow injection over 1 to 2 minutes mini- 
mizes side effects, which are typically infrequent 
and limited to nausea. Furosemide exerts its di- 
uretic effect by inhibiting sodium and chloride re- 
sorption from the proximal and distal tubules and 
the loop of Henle. It is used because of its rapid 
onset of action after intravenous administration 
and its low toxicity. A washout effect can be seen 
in as little as 30 to 60 seconds. Data collection is 
continued for a minimum of 10 minutes and pref- 
erably 15 minutes after diuretic injection. 
Data analysis involves generating a background- 
corrected, time-activity histogram for each renal 
unit, the ureters, and the bladder. The renal re- 
gions of interest include the entire kidney and 
renal pelvis. In normal subjects, the renal time-ac- 
tivity histogram reaches a peak in 3 to 5 minutes; 
this is followed by a spontaneous washout of activ- 
ity that is accelerated after the administration of 
the diuretic. In the normal ureter, there is a flat 
time-activity curve just above background with a 
transient spike of activity reflecting the washout 
from above (Fig 4) .34, 37 
In patients with dilated, nonobstructed collect- 
ing systems, the time-activity histogram demon- 
strates a continuous increase in activity or an in- 
crease to a broad plateau level and then a variable 
degree of washout in response to the diuretic (Fig 
5). 34’37 The larger the collecting system, the less 
“crisp” the response. The time-activity curve asso- 
ciated with a dilated, nonobstructed ureter is sim- 
ilar in appearance.37 
In patients with dilated, obstructed systems, the 
time-activity histogram reveals increasing activity 
or activity that reaches a plateau and then little or 
no response to the diuretic (Figs 6 and 7,A and B). 
14 
In some cases, tracer accumulation actually con- 
tinues to increase, and a potentially confusing pat- 
tern of an initial slight decrease followed by reac- 
cumulation has been described. 
Several important restrictions of the aforemen- 
tioned criteria must be understood for appropriate 
application of the diuretic renogram. Most impor- 
tant, the rationale for the test is not met if renal 
function is so impaired that there is no response 
to the diuretic (Fig 8).37 If the creatinine level is 
above 5.0 mg/dL, the kidney is poorly visualized, or 
the collecting systems are not visualized, the afore- 
mentioned criteria for distinguishing obstructed 
from nonobstructed systems clearly do not apply. 
The ability to change the flow rate is so greatly im- 
paired under these conditions that a washout 
phenomenon would not be observed even in an 
unob$ructed system. Moreover, an “intermediate” 
response must be interpreted with caution. With 
good renal function and a truly unobstructed sys- 
tem, a washout of 50% or greater is typically seen 
within 10 minutes of diuretic injection. Patients 
with “intermediate” or “indeterminant” responses 
merit close follow-up with the further proviso that 
the diuresis renogram is simply one evaluative 
method. The test does not provide a definitive an- 
swer in every case. Systems can also convert from 
one pattern to another if an infectious process is 
part of the clinical problem. 
In addition to the initial diagnosis of urinary 
tract obstruction, the diuresis nanogram is valuable 
in assessing the results of surgery (Fig 9). Residual 
urinary tract dilatiop is extremely common, even 
after successful pyeloplasty or ureteral neocystos- 
tomy. The diuresis renogram provides an objective 
means of demonstrating that the collecting system 
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FIG 4. 
Normal patterns for the renal and ureteral time-activity histograms 
In nonobstructed and nondilated systems. Note the timing relation- 
ship between the accelerated washout from the kidney and the 
spike of ureteral activity. (From Thrall JH, Koff SA, Keyes JW Jr: 
Diuretic radronuclide urography in the differentral diagnosis of hy- 
droureteronephrosis. Semin Nucl Med 1981; 11:89-l 14 Used by 
permission.) 
is unobstructed.38 Renal transplantation also in- 
volves a high incidence of collecting system dila- 
tion, and the diuresis renogram is useful in this 
setting as we11.3g 
RADIONUCLIDE CYSTOGRAPHY 
tract infections. Unremitting reflux may be associ- 
ated with damage to the kidney and may, in later 
life, lead to hypertension and even chronic renal 
failure. In patients adequately treated with anti- 
biotics, vesicoureteral reflux typically resolves with 
time and does not require surgery in most cases. 
Radionuclide methods have become increas- The traditional method for following children 
ingly accepted in the evaluation of vesicoureteral with reflux has been the voiding cystourethro- 
reflux, most importantly in children with urinary gram. However, this radiographic procedure is as- 
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FIG 5. 
Time-activity histograms for dilated, nonobstructed kidneys and 
ureters. The diuretic response IS dramatic and unequrvocal in the 
illustrated curve. Lesser degrees of washout response are fre- 
quently seen in markedly dilated k’idneys and krdneys wrth dimrn- 
[shed functton. (From Thrall JH, Koff SA, Keyes JW Jr: Diuretic 
radionuclide urography in the differential diagnosis of hydro- 
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FIG 6. 
Renal and ureteral time-activity patterns for obstructed systems. 
The renal activity fails to wash out or diminish following diuretic 
injection. (From Thrall JH, Koff SA, Keyes JW Jr: Diuretic radionu- 
elide urography in the differential diagnosis of hydroureterone- 
phrosis. Semin Nucl Med 1981; 11:89-l 14. Used by permission.) 
sociated with a significantly higher radiation dose 
to the gonads than is the nuclear medicine tech- 
nique and is, for a number of reasons, less sensi- 
tive in detecting reflux. The radionuclide study 
permits continuous monitoring during the filling 
and micturition phases.-’ Moreover, the high 
contrast resolution of the radionuclide technique 
permits the detection of reflux volumes on the or- 
der of 1.0 ml. A frequently employed strategy is to 
obtain an initial radiographic study for detailed 
anatomic evaluation, with follow-up studies per- 
formed scintigraphically to minimize the radiation 
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dose to the gonads and to take advantage of the 
high sensitivity of the radionuclide test. 
The radionuclide cystogram is typically per- 
formed as a three-phase procedure: continuous 
monitoring during filling of the bladder, micturi- 
tion, and a postvoiding period. The procedure may 
be done simply to determine the presence or ab- 
sence of reflux or to measure postvoiding residue 
in the bladder. The radionuclide cystogram may 
be modified to record pressure-volume relation- 
ships in the bladder for correlation with time of 
reflux. 
A gamma scintillation camera interfaced to a nu- 
clear medicine computer system is used for the 
procedure. With the patient positioned so that the 
bladder, ureters, and kidneys are in the field of 
view, the study is obtained as a dynamic sequence 
at the rate of one frame every 5 or 10 seconds. An- 
alog images may also be obtained every 30 to 60 
seconds to integrate activity during different 
phases of the study. “mTc as sodium pertechne- 
tate or another nonabsorbable form is used as the 
radiotracer. A solution of 1 mCi/500 ml provides a 
sufficient concentration. 
Catheterization of a child is an important step in 
the procedure, and all personnel involved should 
be taught the appropriate sterile technique. The 
patient’s cooperation is extremely valuable to 
avoid premature voiding around the catheter and 
resultant contamination of the imaging field. The 
bladder should be filled slowly. As capacity is 
reached, voiding may occur spontaneously, espe- 
cially in younger children and infants. 
In a normal study, no tracer is demonstrated in 
the region of the ureters or kidneys (Fig 10). Reflux 
is readily detected by the presence of activity 
above the bladder and may be graded (Fig 11). Willi 
and Treves have suggested that the detailed grad- 
ing system used radiographically is not feasible for 
radionuclide imaging because of the more limited 
spatial resolution.42 However, it is still possible to 
grade the degree of reflux as minimal (reflux con- 
fined to the ureter), mild to moderate keflux 
reaches the pelvicaliceal system), or severe (dis- 
tended collecting system and/or redundant ure- 
ter). 
As noted earlier, one of the advantages of the ra- 
dionuclide technique is continuous monitoring. In 
a small percentage of patients, reflux is demon- 
strated only during the filling phase. In the major- 
ity (80%), reflux is seen during both the filling and 
micturition phase, and in the remainder, it is seen 
only during voiding.41S 42 Although it requires cath- 
eterization of the bladder, the method of direct 
cystography is felt ,to be more accurate than is in- 
direct cystography?3 
The volume of the bladder and the residual vol- 
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FIG 7. 
A, selected images obtarned from the posterior view durtng a druresis renogram. Note the delayed visualization of the left renal collecting 
structures, There is some degree of dilation bilaterally. The tracer was injected at approximately 17 minutes into the study (between the 
time of the second image on the top row and the first image on the bottom row). The collecting structures on the right respond promptly 
to the diuretic. On the left, there is progresstve pooling, particularly in the lower poles. B, time-activity histograms for the bladder (i3) 
and the left (L) and right (R) kidneys. The vertical arrow indicates the time of furosemide (Lasix) administration. The right kidney demon- 
strates a broad, somewhat delayed peak compatible with a degree of dilation. There is some spontaneous washout that is further 
accelerated after administration of the diuretic. The left kidney fails to respond to the diuretic, which indicates a significant mechanical 
obstruction. 
ume after voiding can be readily calculated by 
measuring the change in count rate before and af- 
ter voiding and relating the change to the urine 
volume. This approach assumes a constant atten- 
uation, an assumption that is probably slightly in- 
correct, but reasonable.42 
CAPTOPRIL RENOGRAPHY 
A third potential renal interventional study has 
been proposed for the evaluation of patients with 
suspected renal vascular hypertension. Captopril 
is an angiotensin-converting enzyme inhibitor that 
has been used for the treatment of hypertension. 
Diminished renal function and even renal failure 
have been described in patients receiving captopril 
therapeutically, and captopril is linked to the pres- 
ence of significant renal vascular hypertension.44,45 
The postulated mechanism is a reduction in the 
tone of the postglomerular arterial bed as normally 
mediated by angiotensin II. This process results in 
a decrease in the glomerular filtration rate in pa- 
FIG 8. 
Sequential images in a patient with acute renal failure. Note the failure of the collecting systems to be discretely visualized. There is 
prolonged, rather static retention of tracer bilaterally. In this setting, the diuresis technique is inappropriate. 
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FIG 9. 
Follow-up time-activity histograms from the patient illustrated in Figure 7. Following a left pyeloplasty, there is some response to the 
diuretic, which indicates some relief of the obstruction. Left kidney, middle curve; right kidney, dotted curve; bladder, upper continuous 
CUNe. 
tients with significant obstructions of the renal ar- 
tery. 
Several investigators recognized that the unde- 
sirable effects of captopril on renal function ac- 
tually suggested the possibility of a diagnostic in- 
tervention to enhance the detection of renal 
vascular disease.4648 In brief, a renogram is per- 
formed before and after the administration of cap- 
topril. In normal subjects and hypertensive pa- 
tients without renal vascular disease, captopril 
does not significantly affect the renogram. In pa- 
tients with a significant renal vascular abnormality, 
the renogram is altered, and diminished glomeru- 
lar filtration and diminished effective renal plasma 
flow are demonstrated. The accuracy of plasma 
renin measurements and renal vein renin deter- 
minations in evaluating hypertensive patients has 
also been shown to be improved when using cap- 
topril.4g Early experience in experimental models 
has been very encouraging. Whether this experi- 
ence can be translated from the acute experimen- 
tal model to patients with chronic long-standing 
disease remains to be established, although initial 
clinical results have been promising.50 However, 
this is another elegant example of how, for a par- 
ticular diagnostic purpose, the ability to intervene 
and change a complex physiological system can 
improve the utility of a procedure that had essen- 
tially been abandoned. 
CARDIAC INTERVE2VTIONS 
In many subjects with significant and even po- 
tentially life-threatening coronary artery disease, 
cardiac function is normal under basal or resting 
FIG 10. 
Normal direct radionuclide cystogram. No tracer is seen above the level of the bladder. Apparent perivesicle background activity is due 
to scatter from the photons arising in the bladder. 
18 Curr Probl Diagn Radial, January/February 1989 
FIG 11. 
Abnormal direct radionuclide cystogram. The image on the left was obtained during filling and the figure on the right during voiding. No 
reflux is demonstrated during the filling phase. During the voiding phase, there is significant reflux into the intrarenal collecting structures 
on both sides, which are mildly dilated. 
conditions, and underlying abnormalities in the 
coronary circulation only become manifested un- 
der conditions of exercise or other stress. Clini- 
cally, it has been recognized for decades that pa- 
tients with angina pectoris experience their pain 
in response to physical work, exposure to cold, 
and even emotional upset. These “interventions” 
of normal daily living form the basis for enumera- 
ble forms of cardiac stress testing and interven- 
tions aimed at detecting occult coronary disease 
and measuring cardiac reserve responses. 
In the discussion of cardiac stress testing, it is 
often puzzling to newcomers that significant sten- 
oses of the coronary arteries have so little apparent 
effect on coronary circulation at rest. An under- 
standing of the relationship between flow reserve 
and degree of vessel stenosis is important in de- 
veloping this understanding. In brief, the resting 
coronary blood flow may be augmented as much 
as 5- to s-fold in response to exercise. Thus, even 
a vessel with significant stenosis may still be ade- 
quate under basal conditions. However, exercise or 
other stress increases oxygen demands and, there- 
fore, flow demands. The fixed stenosis then causes 
diminished flow reserve, and ischemia may de- 
velop in the vascular distribution distal to the nar- 
rowing. Thus, the goal of exercise/stress testing in 
cardiac interventional analysis is the same 
whether the measuring technique is an electrocar- 
diogram IECG), a “‘Tl myocardial perfusion scin- 
tigram, or a radionuclide ventriculogram. Only the 
marker of ischemia is different. For the ECG, char- 
acteristic changes, most notably ST segment 
depression, are detected in ischemic areas. Elec- 
trolyte flux across the ischemic cell membranes is 
impaired and causes the characteristic changes 
seen electrocardiographically. With the “‘Tl myo- 
cardial perfusion scan, regional ischemia is mani- 
fested as a relative decrease in blood flow and 
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therefore in tracer delivery as well as a diminished 
ability of the ischemic myocardial cells to accu- 
mulate the tracer. The characteristic appearance 
on the perfusion scan in ischemic areas is a lower 
relative tracer localization than in nonischemic 
areas. For the radionuclide ventriculogram, isch- 
emia is manifested by abnormalities in regional 
wall motion and associated impairment of quanti- 
tative measures of ventricular function, most im- 
portantly the ejection fraction. From the foregoing, 
it should be apparent that, whichever marker of 
ischemia is used, it is vital to the success of the 
procedure that sufficient stress be applied to gen- 
uinely challenge the coronary flow reserve. A num- 
ber of parameters have been used to assess the ad- 
equacy of stress, including the response of the 
heart rate, the blood pressure, and combinations 
of the two. 
THALLIUM 201 MYOCARDLAL PERFUSION 
IMAGING 
In the early experience with radionuclide tech- 
niques for cardiac intervention studies, there was 
a spirited debate over the relative merits of “‘Tl 
perfusion imaging and exercise radionuclide ven- 
triculography. Clinical results with both tech- 
niques appeared reasonable, but in the last half of 
the 1980s the stress thallium scan has become the 
clear-cut procedure of choice in most medical 
centers. There are several reasons for this prefer- 
ence. These include the ease with which the stress 
thallium scan can be “grafted” onto a standard 
treadmill stress ECG evaluation and the relative 
technical simplicity of the procedure. The exercise 
radionuclide ventriculogram approach requires 
specialized equipment such as ECG gating devices 
to control data acquisition and requires significant 
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training of personnel in analysis of the ventriculo- 
graphic data to obtain reproducible results. The 
exercise radionuclide ventriculogram remains im- 
portant in specific circumstances but is clearly not 
used as frequently as “‘Tl imaging in the diagnosis 
of coronary artery disease. 
Although there are various techniques for “‘Tl 
imaging, the basic principles are now well estab- 
lished. The procedure is most frequently per- 
formed in conjunction with a formal treadmill 
ECG. Standard exercise protocols are used, and 
most laboratories adapt the rigorousness of the 
protocol to the patient’s clinical condition. For in- 
jection of the “lT1, an intravenous line is started 
before exercise begins and is maintained at a keep- 
open level. When the physician exercising the pa- 
tient feels that the point of maximum stress is 
being approached or has been achieved, the thal- 
lium is injected as an intravenous bolus in a dose 
of 2 to 3 mCi. Exercise is continued for 1 to 2 min- 
utes if possible to ensure that the initial uptake of 
the tracer reflects the perfusion pattern at peak ex- 
ercise as closely as possible. The thallium is rap- 
idly cleared from the blood with an 85% extraction 
efficiency in the myocardium. Its regional distri- 
bution correlates well with regional perfusion ex- 
cept at extremes of high and low flow.‘l 
In the early experience with “‘Tl stress myocar- 
dial perfusion imaging, there was considerable de- 
bate regarding the ideal time for beginning the im- 
aging procedure. Some investigators advocated 
waiting as long as 15 or 20 minutes to allow the 
complete blood clearance of “‘Tl and its uptake in 
the myocardium. It has now been established that 
imaging should begin as soon as possible follow- 
ing the stress and that a delay of 20 minutes may 
actually reduce the sensitivity of the procedure be- 
cause of early redistribution and masking of some 
exercise-induced abnormalities.52,53 
For the imaging portion of the procedure, either 
planar or tomographic techniques continue to be 
acceptable. The key to success is probably the 
adoption of a standard imaging protocol and its 
meticulous application. For planar imaging, pro- 
tocols based on a fixed time per image are pre- 
ferred over protocols based on counts per image. 
This procedure permits a direct comparison of re- 
gional uptake in the myocardium between early 
and delayed imaging and eliminates the problem 
of changing activity levels in the background, 
which can be confusing in count-based protocols. 
Under the time approach, images are obtained for 
8 to 10 minutes per view. Some authors recom- 
mend beginning with the left anterior oblique view 
because they feel that it provides the greatest di- 
agnostic information. A minimum of three views is 
obtained. For tomographic studies employing sin- 
gle-photon emission computed tomography 
(SPECT), the merits of 180- vs. 360-degree acquisi- 
tion arcs are still being debated.54’55 The weight of 
evidence appears to be shifting in favor of the 180- 
degree-arc approach.55 The arc chosen is from a 
45-degree right anterior oblique to a 135-degree left 
posterior oblique position. This arc minimizes 
soft-tissue attenuation between the heart and the 
detector. To minimize the redistribution phenom- 
enon, data acquisition for tomography should ide- 
ally be kept under 20 to 25 minutes. 
In the initial experience with “‘Tl myocardial 
perfusion imaging, patients received two separate 
injections of the radiotracer to assess the basal up- 
take pattern and the pattern at peak exercise. Po- 
host and coworkers observed that thallium under- 
goes a continuous redistribution process after 
injection56 that permits reimaging after a time de- 
lay to assess whether defects noted at the time of 
initial imaging persist or fill in. Delayed images are 
typically obtained at 2 to 4 hours. It is important 
to standardize the time of delay to provide repro- 
ducible and comparable results between patients. 
The patterns of initial and delayed uptake form 
the basis of the diagnostic scheme for stress “*Tl 
imaging (Table 2). In normal subjects and patients 
without coronary artery disease, the immediate 
postexercise study demonstrates a uniform uptake 
in the myocardium in all views (Fig 12). The uptake 
diminishes but is still uniform at the time of de- 
layed imaging. Several investigators have devel- 
oped quantitative criteria for the percentage of 
“‘Tl that should normally “washout” between 
early and delayed imaging.53Z571 58 The level of exer- 
cise achieved, the length of delay, intercurrent ac- 
tivity, and even the sex of the patient all influence 
these measurements, which makes it difficult to 
provide unqualified quantitative criteria. As a 
broad rule of thumb in subjects achieving good ex- 
ercise levels, a decrease in activity on the order of 
25% to 40% should be seen at 2 hours. 
On “‘Tl scintigrams the hallmark of exercise-in- 
duced ischemia as a marker of coronary artery dis- 
ease is a defect on the postexercise study that 
“normalizes” or becomes less apparent on delayed 
images (Table 2 and Figs 13 and 14,A and B). The 
lower relative flow to the ischemic segment under 
stress conditions results in less tracer delivery and 
uptake. During the several hours of the recircula- 
tion phase, the lower gradient between the isch- 
emit cells and the circulating levels of “IT1 as 
compared with normal areas results in less wash- 
out and, in some cases, an actual net increase in 
tracer activity, which accounts for the normaliza- 
tion phenomenon. Scarred myocardium from a 
prior infarction does not accumulate tracer during 
the recirculation phase and remains photopenic 
on both immediate and delayed images (Fig 15,A 
and B). 
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TABLE 2. 
Diagnostic Criteria for Stress Redistribution Thallium 201 Myocardial 
Perfusion Imaging 
Postexercise 






Normal Normal; no significant coronary 
artery disease 
Normal Transient ischemia; significant 
coronary artery disease 
Abnormal (no change) Prior infarction with scar; significant 
coronary artery disease but no 
evidence of ischemia 
Partial segmental Transient ischemia; significant 
normalization coronary artery disease with 
possible coexisting prior 
myocardial infarction and scar 
Abnormal “Reverse redistribution”: intelmediate 
probability of coronary artery 
disease 
A pattern of “reverse” redistribution has been 
recognized that consists of an apparent relative 
worsening of a stress-induced defect or the devel- 
opment of a new defect on delayed images in a 
previously normal area.5s’ 6o The significance and 
mechanism of this pattern have been studied 
without conclusive results. Silberstein and DeVries 
observed the pattern in 5% of a series of 785 pa- 
tients.60 Eleven of 20 patients undergoing coronary 
arteriography had significant coronary stenoses 
(>50% luminal diameter narrowing). The predic- 
tive value of the sign was only 55%, a lower figure 
than has been reported in some earlier papers.“’ 
The proposed mechanisms are all essentially 
based on the hypothesis that normal and ischemic 
myocardia have different washout rates. In clinical 
practice, it is prudent to record the presence of 
the reverse-redistribution phenomenon while rec- 
ognizing that, by itself, it indicates only an inter- 
mediate likelihood of coronary artery disease and 
may be present in either ischemic or normally per- 
fused areas. 
The interpretation of “‘Tl scintigrams is chal- 
lenging, and a number of pitfalls need to be rec- 
FIG 12. 
Immediate postexercise (top row) and delayed images (bottom row) from a patient with no significant coronary artery disease The initial 
uptake is uniform with a good target-to-background ratio, and there is uniform activity at the time of delayed imaging (anterior 45degree 
left anterior oblique and 70.degree left anterior oblique images from left to right). 
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FIG 13. 
Immediate postexercise (top row) and 2-hour delayed images (bottom row) in a patient with >90% stenosis of the left anterior descend- 
ing coronary artery. Note the large defect in the septum and anterior wall that essentially completely fills in or normalizes at the time of 
delayed imaging. This is the classic pattern of exercise-induced ischemia. The myocardium is still viable, but the reduced blood flow 
during peak exercise results in a relative defect. 
ognized. Some degree of inhomogeneity may result 
iiom background activity and attenuation artifacts. 
In women, attenuation due to an overlying breast 
can cause spurious defects, and some clinics use 
a breast binder to minimize the effect. The breast 
artifact can usually be recognized by a pattern of 
attenuation that often affects more than one myo- 
cardial region as well as the adjacent background 
areas. The left hemidiaphragm can also cause spu- 
rious defects, depending on patient position dur- 
ing imaging. The gamma camera should be moved 
to obtain the lateral view while the patient remains 
supine. The potential for diaphragmatic attenua- 
tion artifact can be further reduced by using a 
steep left anterior oblique projection rather than a 
true left lateral. Some investigators have advocated 
a sitting position. 
Occasionally, significant “‘Tl will accumulate in 
the venous structures of the arm (see Fig 15,B). 
This distribution of the radiotracer represents a 
reservoir that can actually alter quantitative wash- 
out parameters and confuse image interpretation. 
Injection into the medial or basilic system mini- 
mizes the problem. The subdiaphragmatic struc- 
tures and general background should also be as- 
sessed in all cases. If patients have achieved 
maximum exercise, blood flow is diverted from the 
splanchnic bed, and there will be minimal or no 
activity visualized in the liver. With minimal or in- 
adequate exercise, hepatic activity is frequently in- 
tense. 
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The amount of lung background has become 
recognized as an important secondary diagnostic 
parameter.61’ 62 Patients experiencing impaired ven- 
tricular function together with increased pulmo- 
nary venous pressure during exercise demonstrate 
varying degrees of increased thallium localization 
in the lung (see Figures 15,A and 14,A and B). Lung 
uptake exceeding 50% of the myocardial level is 
definitively abnormal and, in some cases of “bal- 
anced” three-vessel disease, may be the only indi- 
cator of abnormality. Variable degrees of physio- 
logical apical thinning are seen on “‘Tl 
scintigraphy. Each observer must develop a feeling 
for the range of normal variation, but in general, 
the apical defect should be small and represent 
only a few degrees of the circumference. The valve 
planes of the heart are usually not a diagnostic 
problem and are visualized as areas of normally 
diminished activity. However, the orientation of 
the heart varies significantly between subjects and 
must be taken into account, especially in the pre- 
sentation of tomographic data. 
The accuracy of stress “‘Tl scintigraphy for the 
detection of coronary artery disease has been the 
subject of literally dozens of investigations over the 
past decade.63-72 Okada and coworkers summa- 
rized the literature reports for planar thallium im- 
aging and visual nonquantitative interpretation of 
images .72 In 1,817 patient studies from 24 series, 
exercise “‘Tl studies had a sensitivity of 82% and 
a specificity of 91% in detecting coronary artery 
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FIG 14. 
A, immediate postexercise images in a patient with a significant 
left anterior descending lesion. There is diminished relative activity 
in the septal and apical areas. There is increased lung back- 
ground. The lack of activity below the heart in the structures of the 
splanchnic bed indicates that a good level of exercise was 
achieved. B, two-hour delayed images reveal an essentially com- 
plete fill-in or normalization, The clearance of the lung background 
activity and the increase of activity in the liver are best seen by 
comparison of the respective 45degree left anterior oblique views 
(upper left). 
disease. Exercise ECG results in the same patient 
population yielded a sensitivity of 60% and a spec- 
ificity of 81%. 
More recently, quantitative and tomographic 
methods have been applied in an attempt to im- 
prove study accuracy and reproducibility of inter- 
pretation.53-55, 73-82 The most widely used quantita- 
tive method involves the creation of a 
circumferential profile of thallium uptake in the 
myocardium for postexercise and delayed im- 
ages,77J 78 with a calculation of the washout per- 
centages and a comparison to “standard” curves 
from populations of normal subjects or subjects 
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FIG 15. 
A, immediate poststress images in a patient with a known prior 
inferior and posterior wall infarction. Note the greatly diminished 
activity seen in the inferior wall and posterior wall and manifested 
on all three views. (Top row, 45degree left anterior oblique; bottom 
row, 70-degree left anterior oblique). B, corresponding 2-hour de- 
layed images in the same patient reveal no fill-in or normalization 
of the defect. This is the classic pattern of a fixed or irreversible 
defect in an area of myocardial scar due to prior infarction The 
early lung uptake on the poststress images that clears at the time 
of delayed imaging indicates some degree of congestive failure 
during exercise. Also note the.linear activity on the delayed left 
anterior oblique view due to “hang-up” of tracer in the arm veins 
with very low probabilities of coronary artery dis- 
ease (Figs 16 and 17) .57, 588 7gS ” Garcia and cowork- 
ers have described a unique extension of the quan- 
tification of “‘Tl tomographic images to create a 
polar map .‘O In essence, the polar map depicts 
nested circumferential profiles from the apex to 
the base, which provides a means for presenting 
regional uptake data from an entire set of tomo- 
graphic slices in one two-dimensional image. 
The accuracy of quantitative analysis techniques 
remains under investigation. In one multicenter 
trial that compared circumferential profiles of 
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FIG 16. 
Circumferential profiles in the 45- and 70.degree left anterior oblique projections from the patient illustrated in Figure 12 The upper 
curve in each panel represents data from the patient. The darker lower curve is the lower limits of a normal profile derived from a patient 
population with a ~1% probability of coronary artery disease. Note that in each view the patient’s profile curve remains above the lower 
limits of the normal curve. Note also the significant variation in each view at different points around the perimeter. 
stress and washout studies with statistically de- 
rived normal limits, the sensitivity for detection of 
coronary artery disease was 82% and the specific- 
ity was 83% .83 The quantitative techniques also 
permit a more detailed regional analysis of sensi- 
tivity and specificity in the major arterial distribu- 
tions. The highest sensitivity in the study was ob- 
tained for the right coronary artery and left 
anterior descending artery systems, while the 
highest specificity was seen for the left circumflex 
artery. The low sensitivity for left circumflex artery 
disease detection is consistent with previous 
planar studies involving visual interpretation.“3 The 
posterior location of the circumflex distribution 
permits evaluation in only one view by planar im- 
aging. 
In the current climate of increased awareness of 
medical costs and the need to assess the utility of 
diagnostic and therapeutic procedures, it is logical 
to try to identify those patients who might benefit 
most from stress “‘Tl imaging. From the stand- 
point of diagnosis only, patients with classic his- 
tories of angina pectoris have an 85% or greater 
probability of having anatomically significant cor- 
onary artery disease.84 For these patients, a posi- 
tive radionuclide stress test response would not 
alter the clinical decision to study the patient for- 
ther, nor would a negative test result reduce the 
likelihood of disease to a low enough point to 
change the course of events diagnostically. Like- 
wise, in patients with a very low pretest probability 
of disease, positive or negative noninvasive test re- 
sults alone may not significantly alter patient man- 
agement. It has been suggested in a number of 
analyses that the patient group with intermediate 
probabilities of disease (30% to 70%) may benefit 
most from noninvasive testing.85 In this range of 
probabilities, given the accuracy of “‘Tl scintigra- 
phy, a positive or negative test result has a signifi- 
cant impact in determining the probability of dis- 
ease. Patients with atypical chest pain, smoking 
history obesity, hypertension or a family history of 
hypertension, but without classic angina often fall 
into this intermediate-probability category. Hamil- 
ton has calculated that (assuming a test sensitivity 
of 90% and a specificity of 80%) for a patient with 
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a pretest probability of disease in the 50% range 
the post-test probability rises to higher than 80% if 
the radionuclide study is positive and falls to 
lower than 15% if it is normal.8” 
The use of probability theory and, in particular, 
Bayes’ theorem of conditional probability further 
illustrates the difficulty of screening in a large pop- 
ulation of patients with a low disease prevalence. 
For example, with a test sensitivity and specificity 
of 90% and 80% applied to a population of 1,000 
individuals with a disease prevalence of approxi- 
mately 5% (i.e., 50 with coronary artery disease 
and 950 without), 45 patients would have true pos- 
itive test results, and 190 would have false-positive 
results. In this example, the positive predictive ac- 
curacy would only be 20% (45~~5). If diagnosis 
and decision making for referral to angiography 
were based on the test results alone, a large num- 
ber of patients without disease would be studied. 
This example illustrates the need to put each test 
result into the context of the overall clinical pic- 
ture. 
Pharmacological intervention has been pro- 
posed as an alternative to d_vnamic isotonic leg ex- 
ercise for coronary arte:ry disease detection b-v ““~1 
perfusion imaging.xfi’X7 The preferled agent at’- 
pears to be dipyridamole, although this drug is not 
yet approved for routine clinical use by intrave- 
nous administration. Dipyridamole is a potent car- 
onary vasodilator with minor systemic effects. Its 
use has been shown to cause a 3.5- to 4-fold in- 
crease in coronary blood flow together \;\ith a 20% 
to 40% increase in the heart rate and slight but 
significant decline in the blood pessure. The ratio- 
nale for using dipyridamole in conjunction with 
“‘IT1 scintigraphy is that the flow reserve of abnor- 
mal coronary arteries with fixed mechanical ste- 
nosis is more limited than is the flow reserve of 
normal vessels. Therefore, tracer delivery is selec- 
tively enhanced in the “watershed” of normal ves- 
sels, whereas regional areas of relative photopenia 
are seen in the distribution of diseased vessels that 
cannot respond to the drug. 
The protocol for dipyridamole-“O’T1 scintigraphy 
involves the slow intravenous infusion of the drug 
over a 4-minute period at a total dose of 0.56 mg/ 




.indiuidual and normal 
stress curves for a 
view 
NORMAL ----- 
INDIVIDUAL . . . . . 
FIG 17. 
Circumferential profiles from the patient illustrated in Figure 13 with significant coronary artery disease Note that the patient’s curve 
(//ghter dotted curve) falls below the lower limits of a normal curve on each view. All areas falling below the normal curve are regarded 
as demonstrating relative ischemia as compared with the area above the normal-limits curve. 
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kg. Tracer is injected 4 minutes after the infusion, 
and imaging is begun another 5 minutes thereaf- 
ter.8G88 
The incidence of angina is lower with dipyrida- 
mole than with maximum dynamic exercise. Ami- 
nophylline is an antidote to dipyridamole and may 
be given in a dose of 50 to 150 mg intravenously 
over 1 to 2 minutes for intervention-induced an- 
gina.” The drug is otherwise generally well toler- 
ated, although some patients experience head- 
ache, dizziness, or nausea. 
The accuracy of the dipyridamole-““‘Tl tech- 
nique is comparable to that of stress ‘“‘Tl imaging. 
Reported sensitivities have ranged from 73% to 
95% and specificities from 67% to 100%.86-88 
Some workers have attempted to augment the 
effect of dipyridamole by having the patient also 
perform handgrip isometric exercise at the time of 
tracer administration. The use of oral rather than 
intravenous dipyridamole has also been investi- 
gated.” The onset of drug action is less predict- 
able, and in the limited experience available for re- 
view, the oral approach appears less sensitive. 
There are a number of reasons for performing a 
thallium stress scan in addition to diagnosing cor- 
onary artery disease. The degree of abnormality 
demonstrated by perfusion scintigraphy has been 
shown to have independent prognostic value, and 
information concerning the patient’s exercise tol- 
erance may be important in recommending spe- 
cific management. Patients with known lesions in 
the coronary arteries may be referred to evaluate 
the functional significance of the stenoses since 
the angiographer can assess the degree of mor- 
phological narrowing but not the flow impairment 
associated with a given lesion. The outcome of an- 
gioplasty or coronary artery bypass grafting can 
also be assessed by imaging before and after the 
therapeutic intervention. 
EXERCISE ZMDIONUCLIDE VENTRZCULOGZWPHY 
As noted earlier, in exercise radionuclide ven- 
triculography, the fimctional sequelae of exercise- 
induced ischemia are detected. On ventriculo- 
graphic studies obtained at rest or exercise, areas 
of scarred myocardium due to prior infarction 
demonstrate abnormal wall motion with failure to 
contract. Ischemia is inferred on exercise radio- 
nuclide ventriculograms from the development of 
new wall motion abnormalities that were not pres- 
ent on baseline studies and/or the failure of the 
ejection fraction to increase. 
The exercise radionuclide ventriculogram can be 
performed either as a first-pass (first-transit) study 
following a bolus injection of radiopharmaceutical 
or as an equilibrium gated blood pool procedure 
using ““Tc-labeled red blood cells9” ‘* The advan- 
tages and disadvantages of the two approaches 
have been debated in the literature. The first-tran- 
sit technique requires high-count rate instrumen- 
tation, and at least until recently, the count rate 
capability of standard gamma scintillation cameras 
has not been ideal for first-pass studies. Multicrys- 
tal detectors with a peak count rate capability of 
200,000 counts/set or more have been used suc- 
cessfully. Both approaches permit baseline studies 
and studies at increasing levels of exercise. Re- 
peated injections of tracer are required for the 
first-transit studies. A major putative advantage of 
the first-transit approach is the rapidity of data 
collection to capture ventricular function at peak 
exercise. The equilibrium blood pool technique 
has the advantage of better counting statistics 
through imaging over a number of cardiac cycles 
but the disadvantage of being sensitive to cardiac 
arrhythmias and patient motion. The greater avail- 
ability and versatility of the single-crystal gamma 
camera and the superior image quality of the gated 
equilibrium blood pool study have made this ap- 
proach the more widely available in current prac- 
tice. 
The setup and logistics for exercise radionuclide 
ventriculography are formidable. For gated equilib- 
rium blood pool studies, the patient is monitored 
by an ECG machine modified to provide an R-wave 
timing pulse to the computer. The R-wave is the 
electrical marker of end-diastole and a logical 
point in the cardiac cycle at which to begin data 
collection. The stability of the electrical signal 
must be good so that accurate timing pulses are 
provided during exercise. Otherwise, spurious 
skeletal muscle activity or noise spikes can trigger 
the data-recording sequence. A special exercise 
apparatus is required to permit the patient to ex- 
ercise to his full capacity during continuous im- 
aging. Maximum exercise is achieved in most lab- 
oratories by using a bicycle ergometer attached to 
a sturdy table. The question whether upright or 
supine exercise is preferable has not been fully re- 
solved, but many of the commercially available ex- 
ercise tables permit a range of patient positioning. 
The actual exercise protocol is again tailored to 
the overall condition of the patient and typically 
involves 25- to 50-W increments after a short 
warm-up period. At each successive level of exer- 
cise, the heart rate is allowed to stabilize for 1 to 2 
minutes, and this is followed by 1 to 2 minutes of 
data collection. In graded exercise, it is desirable 
to keep each level of exercise at no more than 3 
minutes to avoid leg fatigue prior to achievement 
of maximum exercise. Many laboratories record a 
postexercise study during the time when the heart 
is ‘unloaded” by peripheral vasodilation. The ma- 
jor technical limits to the procedure are faulty ECG 
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FIG 18. 
A, end-diastolic and end-systolic images from a radionuclide ven- 
triculogram obtained at rest in a normal subject. The arrow points 
to the apex of the left ventricle at end-systole. Note the uniform 
emptying of both the right and left ventricles between end-diastole 
and end-systole. B, corresponding end-diastolic (ED) and end- 
systolic (ES) views obtained at peak exercise. Note that the 
amount of tracer in the end-systolic image of the left ventricle is 
significantly less than on the resting study (arrow). This pattern il- 
lustrates the normal response to exercise. 
FIG 19. 
gating and excessive patient motion during exer- 
cise. 
The analysis of exercise radionuclide ventricu- 
lograms includes an assessment of the baseline 
study and the studies obtained at each exercise 
level to determine the ejection fraction and assess 
regional wall motion. In normal subjects, wall mo- 
tion should be uniform at rest, there should be no 
regional wall motion abnormalities apparent dur- 
ing exercise, and the ejection fraction should in- 
crease by 5% or more (Fig 18,A and Bl. In patients 
with significant coronary artery disease, wall mo- 
tion abnormalities become manifest at high levels 
of exercise, and there is a failure of the ejection 
fraction to improve or even a decline in the ejec- 
tion fraction (Fig 19&D).“’ Various investigators 
have suggested measurement of other quantitative 
parameters such as the rate of ventricular empty- 
ing and filling (dV/dt). Analytic interest has also fo- 
cused on parametric analysis (phase analysis to 
detect subtle areas of ventricular asynnergy not 
seen on the closed-loop cinematic display. These 
alternative methods have not yet become useful in 
routine clinical practice. 
The accuracy of exercise radionuclide ventricu- 
lography has been studied in a number of institu- 
tions. Sensitivities of 85% to 95% have been re- 
ported and specificities from 54% to 100%.y”~y’ 
Careful examination of the literature in this area 
reveals that varying patient populations, study 
conditions, and diagnostic criteria make compari- 
sons of clinical research data difficult. For exam- 
ple, Borer and coworkers, who first described the 
X 
D 
A, end-diastolic (ED) and end-systolic (ES) images obtained at rest in a patient with significant coronary artery disease No abnormality 
of ventricular function is apparent. The left ventricle IS emptied uniformly and well between end-diastole and end-systole (arrow). B, 
corresponding end-diastolic and end-systolic images obtained during peak exercise reveal a failure of the ventricular emptying to im- 
prove. The amount of activity remaining in the left ventricle at end-systole (arrow) is far greater than that at rest and indicates exercise- 
induced ventricular dysfunction due to exercise-induced ischemia. The right ventricle continues to contract normally. C and D, time- 
activity or time-volume curves obtained at rest (C) and exercise (D) reveal a significant decline in the ejection fraction (E F ) from 70% 
to 45%. In normal sub)ects, the ejection fraction should increase in response to exercise. 
Curr Probl Diagn Radiol, January/February 1989 27 
technique, used supine bicycle exercise and dis- 
continued treatment with antianginal drugs for the 
procedureso, g3 Jones and coworkers reported on 
patients exercised upright who continued to take 
their cardiac drugs.‘l In some series, patients with 
abnormal baseline studies have been included, a 
practice that tends to increase the apparent sen- 
sitivity of the procedure. Another issue is whether 
a given series included patients unable to achieve 
maximum exercise. Monitoring and documenta- 
tion of the total length of exercise, external work 
load (ergometer setting), pressure-rate product 
(blood pressure and heart rate), ECG response, and 
patients’ symptomatic responses have been highly 
variable in reported series. The significance of ex- 
ercise level is well illustrated in Brady and cowork- 
ers’ series.% The sensitivity for detecting coronary 
artery disease was 65% in patients who exercised 
to the point of chest pain, the development of l.O- 
mm ST segment depression or more, or a pres- 
sure-rate product (systolic blood pressure times 
heart rate) of 25,000 or greater. The sensitivity in 
patients failing to achieve any of these criteria was 
62% (P < .02). In critically evaluating the literature, 
not only for exercise radionuclide ventriculogra- 
phy but for all forms of stress testing, these factors 
must be kept in mind. In clinical practice, deci- 
sions must be made for every patient, including 
those who cannot achieve adequate exercise or 
who cannot be weaned from their cardiac medi- 
cations. 
ALTERNATIVES TO LEG EXERCISE 
Table 3 provides a summary of alternatives to 
treadmill or bicycle exercise. All of these have been 
explored for the purpose of detecting coronary ar- 
tery disease. None of the other physiological or 
physical techniques has shown results compara- 
ble to those of dynamic isotonic exercise. Sus- 
tained isometric contraction results in an in- 
creased blood pressure and heart rate. Clinically, 
the test is performed with a handgrip dynamome- 
ter. The maximum force that a patient can gener- 
ate is first determined, and the test is performed 
at 25% to 33% of the maximum voluntary contrac- 
tion for 3 to 5 minutes. Sufficient experience has 
not been presented in the literature to develop a 
TABLE 3. 
Alternative to Dynamic (Leg1 Exercise 
Isometric (handgrip) exercise 
Cold pressor testing 
Atrial pacing 
Postextrasystolic potentiation 
Pharmacological stress Icatecholamines) 
consensus of sensitivity and specificity, although 
the accuracy is clearly lower than that of dynamic 
exercise. Patients with coronary artery disease de- 
velop regional wall motion abnormalities and de- 
creases in the ejection fraction.g6,g7 However, some 
normal subjects apparently also demonstrate a 
decrease in ejection fraction with isometric exer- 
cise. 
Cold pressor testing, atrial pacing, and studies 
aimed at evaluating postextrasystolic potentiation 
have all aroused passing interest.g”‘02 Cold pressor 
testing is performed by immersing one hand in 
ice-cold water (0 to 2°C) for 2 to 3 minutes. In two 
series reported by Manyari et al. and by Jordan et 
al., respectively, the sensitivity of this test was sig- 
nificantly less than for dynamic exercise.“’ ” In the 
latter series, only 24 of 41 patients (57%) demon- 
strated an abnormal response to cold pressor test- 
ing as compared with 34 of the 42 (81%) demon- 
strating wall motion abnormalities during dynamic 
exercise.” 
GASTROINTESTINAL STUDIES 
Diagnostic studies using radionuclide tech- 
niques have been developed to detect gastro- 
esophageal reflux and to measure esophageal and 
gastric function. The unique ability to quantita- 
tively measure the passage of a radioactive tracer 
through the luminal structures of the gut has af- 
forded the ability to assess functional change in 
response to drugs for both diagnostic and thera- 
peutic purposes. 
GASTROESOPHAGEAL REFLCJX 
Malmud and Fischer have demonstrated the 
utility of radionuclide techniques for detecting 
gastroesophageal reflu~.~~~-‘~~ The procedure in- 
volves administering 0.5 mCi of ggmTc-pentetate 
(DTPA) or sulfur colloid in 300 ml of isotonic sa- 
line. Serial 30-set/frame images are obtained, first 
with the patient upright and then supine. Reflux is 
enhanced by exerting epigastric pressure in 20- 
mm Hg increments to a maximum of 100 mm Hg. 
An abdominal binder containing a pressure cuff 
and manometer is used for this interventional ma- 
neuver. In adults, less than 5% of the tracer should 
be demonstrated in the esophagus. In addition to 
diagnosing reflux, the technique can be used to as- 
sess the effect of pharmacological agents such as 
bethanechol, a cholinergic agonist that increases 
the lower esophageal sphincter tone and reduces 
reflux. Metoclopramide has some cholinergic ago- 
nist effects and ma; also reduce reflux. The effi- 
cacy of agents such as alginic acid, which prevent 
reflux by forming a barrier layer over the stomach 
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contents, is also readily evaluated by the radionu- 
elide technique.“’ 
GASTRIC EMPTYING 
The physiology of gastric motility and the rates 
of gastric emptying have been extensively studied 
with radionuclide techniques.lo7 In fact, the inves- 
tigation of agents to simulate liquid and solid 
meals has almost become a subculture in radi- 
opharmaceutical development.“’ Perhaps the ear- 
liest and most exotic radiopharmaceutical to be 
evaluated for this purpose was radiolabeled 
chicken liver.10g The procedure involved injecting 
gsmTc-sulfur colloid into a live chicken followed by 
sacrifice of the chicken after the tracer had been 
taken up in the liver. The radiolabeled liver was 
then cooked and fed to the patient. This in viva 
labeling method guaranteed that the radionuclide 
remained attached to the parent material, but as 
might be anticipated, patient and laboratory ac- 
ceptance was not uniformly good, thus prompting 
the development of alternative radiotracers for the 
analysis of gastric emptying. The most widely ac- 
cepted agents for this purpose in current practice 
are gg”‘Tc-sulfur colloid-labeled eggs for the inves- 
tigation of solid gastric emptying and ““““I’c- or 
‘llIn-pentetate (DTPA) for liquid emptying studies. 
As with studies of gastroesophageal reflux, a 
central interest in gastric emptying studies is the 
FIG 20. 
A, sequential l-minute images from a gastric emptying study obtained with a liquid meal. Very little activity has left the stomach and 
entered the small bowel during the first 12 images (top two rows). The patient received metoclopramide at approximately 12 minutes. 
After a few minutes’ delay, a significant acceleration is demonstrated with tracer entering the small bowel. This pattern illustrates a 
positive response to metoclopramide and confirms the likelihood of therapeutic efficacy of the drug in this patient. B, corresponding 
time-activity histogram reveals essentially no emptying during the premetoclopramide phase of the study. The curve is flat After a few 
minutes’ delay, there is a marked downsloping of the curve that corresponds to the observed emptying of tracer into the small bowel. 
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response of the physiological process to various 
pharmacological interventions. For example, me- 
toclopramide is used to promote gastric emptying 
in diabetics with gastroparesis. The success of this 
therapy depends, however, on some preservation 
of cholinergic activity. When using nuclear tech- 
niques, the rate of gastric emptying can be mea- 
sured before and after the administration of me- 
toclopramide intravenously as a predictor of 
response to chronic oral therapy (Fig 20,A and 
B).ll’ The side effects of metoclopramide are sig- 
nificant enough that a rational demonstration of 
the therapeutic effect is valuable in deciding 
whether to continue or discontinue therapy. This 
is just one example of literally dozens illustrating 
the use of pharmacological interventions in study- 
ing gastric physiology. 
GASTROINTESTINAL BLEEDING 
A number of interventions have been described 
to enhance the radionuclide detection of gastroin- 
testinal bleeding. In the case of Meckel’s divertic- 
ulum, bleeding is invariably associated with the 
presence of gastric mucosa in the diverticulum. 
The bleeding is usually from ulcerations in the ad- 
jacent ileal mucosa that result from acid and pep- 
sin secretion by the ectopic mucosa. The rationale 
for the detection of Meckel’s diverticulum by ra- 
dionuclide techniques is the observation that 
YvmT~ as sodium pertechnetate is actively trapped 
and secreted by the gastric mucosa.lll The imaging 
technique involves administering 10.0 mCi ggmTc- 
pertechnetate intravenously followed by imaging 
of the patient’s abdomen at 5-minute intervals for 
1 hour.112 Pentagastrin, which increases gastric 
blood flow and stimulates the secretion of acid, 
has been used to enhance the localization of 
ggmTc-pertechnetate in Meckel’s diverticulum.1’3-115 
Although significant clinical data are lacking, cases 
have been reported in which an initial failure to 
detect a Meckel’s diverticulum was rectified by ad- 
ministering pentagastrin and repeating the 
study? 
Another interesting enhancement method used 
adjunctively in the detection of gastrointestinal 
bleeding is the administration of glucagon to par- 
alyze the gut. *I6 “““Tc-labeled sulfur colloid and 
red blood cells have demonstrated significant clin- 
ical efficacy in detecting active gastrointestinal 
bleeding; however, accurate localization of the 
bleeding site may be problematic due to peristaltic 
activity and movement of radiotracer away from its 
original site of deposition. For bleeding sites in the 
small intestine, the intensity of peristaltic activity 
and rapidity of tracer disbursal may actually result 
in a false-negative study or a study demonstrating 
only diffuse activity. By paralyzing the gut with 
FIG 21. 
A 99mTc-red blood cell gastrointestinal bleeding study. The image 
wk obtained approximately 2 hours after administration of the red 
cells. There is greater than expected activity in the left part of the 
midabdomen, but no definite localized bleeding site is demon- 
strated. B, following the administration of glucagon and continued 
imaging at 1 O-minute intervals, an unequivocal focal area of tracer 
localization is demonstrated in the left part of the midabdomen lat- 
erally. 
glucagon, the radiotracer is allowed to pool at the 
bleeding site, thus enhancing its localization and 
the lesion’s detectability (Fig 21A and B). A dose of 
0.5 to 1.0 mg of glucagon is administered intrave- 
nously followed by sequential imaging using a 
standard 5-minute-per-view format. The effect of 
the glucagon diminishes after 30 minutes, and if 
suspicion of active bleeding remains high, an ad- 
ditional dose may be administered. 
HEPATOBILIARY IMAGING 
Hepatobiliary interventions have become impor- 
tant adjuncts to imaging in both the pediatric and 
adult age groups. In pediatric practice, hepatobili- 
ary imaging with ‘311-rose bengal or, more re- 
cently, ““Tc-iminodiacetic acid (IDA) derivatives 
(e.g., disofenin, merbrofenin, lidofenin) is used to 
distinguish neonataf hepatitis from biliary atresia. 
However, mse bengal and the IDA derivatives com- 
pete with bilirubin for the hepatic organic anion 
excretion pathway, and false-positive studies may 
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result in some cases of abnormally high bilirubin 
levels (Fig 22,A and B). Phenobarbital stimulates 
overall hepatic transport and excretory functions 
and thereby represents a useful intervention to 
promote the hepatocyte excretion of these radi- 
otracers.‘17, ‘18 The suggested dose of phenobarbi- 
tal is 5 mg/kg of body weight per day in divided 
doses for at least 5 days before the “““‘Tc-IDA 
study. 
Majd and colleagues reported prephenobarbital 
and postphenobarbital studies in 16 patients. The 
initial study demonstrated no hepatobiliary excre- 
tion of the “YmTc-IDA derivative in any patient.““’ lzo 
Six of these patients demonstrated excretion fol- 
lowing phenobarbital administration. Nine of the 
ten remaining subjects were shown to have biliary 
atresia at surgery. Anecdotal experience in smaller 
series has supported these results. 
The principal clinical use of the 9g”Tc-IDA deriv- 
atives is in the differential diagnosis of abdominal 
pain, specifically in patients with suspected acute 
cholecystitis.lzl, 122 Unequivocal visualization of the 
gallbladder essentially rules out acute cholecystitis 
except in a small percentage of patients with acal- 
culous cholecystitis in whom the gallbladder is vi- 
sualized. The predictive accuracy of a negative 
study is high enough to alter clinical decision 
making from “surgery” to “no surgery.“123 How- 
ever, the predictive accuracy of positive results, i.e., 
failure to visualize the gallbladder, is much lower 
in clinical situations in which the flow of bile into 
the gallbladder is diminished.‘“’ In palients who 
have been fasting for prolonged periods of time or 
who are undergoing hyperalimentation, the gall- 
bladder is not stimulated to contract; there is a re- 
sultant increase in bile viscosity and a stasis of t)ilc: 
flow. In this situation, gallbladder entry of the he- 
patobiliary radiotracers is restricted. Numerous in- 
vestigators have shown a high incidence of false- 
positive hepatobiliary studies in chronically ill, de- 
bilitated, and hospitalized patients, probably for 
this reason. 
Since the phenomenon of impaired biliary kinet- 
ics is somewhat predictable from the patient’s his- 
tory, strategies have been developed to convert po- 
tentially false-positive studies to true negative 
studies.lZS One approach is to pretreat patients 
who have been fasting for prolonged periods of 
time with a cholecystogogue. Either cholecystoki- 
nin or sincalide (Kinevacl, a drug consisting of the 
C-terminal octapeptide portion of cholecystokinin, 
can be used. The dose of sincalide is 0.02 pg/kg of 
body weight. The drug is administered intrave- 
nously and should be injected slowly to avoid in- 
ducing a spasm of the gallbladder neck.“’ Chole- 
cystokinin and sincalide produce contraction of 
the gallbladder with relaxation of the sphincter of 
Oddi. The maximum effect is reached 5 to 15 min- 
utes after injection. The ““Tc-IDA agent is admin- 
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22. 
‘mT~-IDA imaging in a patient with suspected congenital biliary atresia Imaging without pretreatment with phenobarbital 
al excretion of activity into the gut. The bladder (closed arrow) and the kidneys (open arrows) are visualized and should 
3ken for tracer activity in the gut. B, following pretreatment with phenobarbital, the patient now demonstrates uptake in the g 





cystokinin or sincalide administration so that the 
maximum excretion of the radiotracer into the bil- 
iary system occurs during the refilling phase of the 
gallbladder. Sincalide is usually well tolerated. Pa- 
tients may complain of abdominal discomfort and 
the urge to defecate, and occasionally nausea, diz- 
ziness, or flushing may occur. 
It has recently been noted that pretreatment 
with sincalide may delay the time of visualization 
of the tracer in the small bowel, possibly causing a 
misdiagnosis of common bile duct obstruction. 
The pathophysiologv of this observation has not 
been established but may relate to diversion of bile 
to the gallbladder during its filling phase. 
An alternative to the pretreatment approach is 
to administer the ggmTc-IDA agent and image se- 
quentially in the usual manner over a period of 1 
to 2 hours. If the gallbladder is visualized, no in- 
terventional maneuver is required. If the gallblad- 
der fails to be visualized, it is possible to adminis- 
ter the cholecystogogue, and after an appropriate 
30-minute interval, a second dose of the YgmTc-IDA 
agent is injected (Fig 23,A and B).lz5 The choice of 
which approach to use is obviously at the discre- 
tion of each institution, although pretreatment in- 
tervention results in shorter study times. 
An interesting alternative intervention proposed 
for the enhancement of gallbladder visualization is 
the administration of intravenous morphine. The 
rationale is that morphine causes constriction of 
the sphincter of Oddi with a resultant increase in 
the pressure in the common bile duct and in- 
creased flow of bile and radiotracer into the gall- 
bladder. The technique is applicable if tracer is 
clearly demonstrated in the common duct. The 
dose of morphine sulfate is 0.04 mg/kg of body 
weight and is administered intravenously over 3 
minutes. In the original series by Choy et al., the 
specificity of hepatobiliary imaging improved from 
83% to 100% with the morphine intervention.lZ6 In- 
terestingly, morphine-induced contraction of the 
sphincter of Oddi may give the false impression of 
common bile duct obstruction in patients receiv- 
ing this drug for the control of pain. As for all other 
procedures where incidental drug therapy may al- 
ter the test results, patients undergoing YY’“Tc-IDA 
imaging should be questioned for drug histories, 
especially for the use of morphine or morphinelike 
products (Fig 24,A and B). 
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FIG 23. 
A, sequential images from a 99mTc-lDA study in a patient with sus- 
pected acute cholecystitis. No uptake is demonstrated in the gall- 
bladder. Imaging was continued for another 90 minutes without 
visualization of the gallbladder. 8, reinjection of g9mT~-IDA was 
performed 20 minutes after treatment with sincalide. Note the ab- 
sence of gallbladder activity on the 20., 25., and 30.minute im- 
ages. The gallbladder is unequivocally demonstrated on the 40- 
minute right anterior oblique view. The use of sincalide in this case 
converted a false-positive study to a true negative study 
In the early experience with 9s”‘Tc-IDA hepato- 
biliary imaging, there was concern that acalculous 
cholecystitis could cause false-negative resu1ts.l” 
Some authors suggested that as many as 4% of pa- 
tients presenting with cholecystitis might fall into 
this category. The phenomenon is apparently a 
real one but has not proved to be common or clin- 
ically important. Nonetheless, if the gallbladder is 
visualized and there is still a high degree of clinical 
suspicion that the patient has acalculous chole- 
cystitis, a cholecystogogue may be administered. 
Since the normal gallbladder responds immedi- 
ately and vigorously to cholecystokinin or sincal- 
ide, such a response rules out acalculous chole- 
cystitis.l” The inflamed, edematous gallbladder 
wall in cases of cholecystitis does not respond or 
responds poorly to this intervention. 
A limited number of centers have reported an- 
other potential use for cholecystogogues in the 
evaluation of patients presenting with persistent 
postprandial right upper quadrant pain and biliary 
colic but with normal study findings of the gall- 
bladder by oral cholecystography, ultrasound, or 
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FIG 24. 
A, anterior view of a “““Tc-IDA study obtalned 120 minutes after tracer administration There is intense tracer accumulation in the 
gallbladder with visualization of the common duct but no activity in the small bowel The patient was receiving morphine for the control 
of pain Failure to visualize the small bowel at 120 minutes is distinctly abnormal and raises the possibility of a common bile duct 
obstruction. B, a repeat image obtained 20 minutes after the administration of sincalide reveals significant excretion of tracer into the 
duodenum and proximal jejunum, thereby ruling out a common duct obstruction but illustrating the potential for false-positive interpreta- 
tion unless a detailed drug history is elicited. 
upper gastrointestinal series.‘25,“’ This symptom- 
atology is felt to be due to noncalculous partial 
cystic duct obstruction.12x The rationale for the use 
of cholecystokinin or sincalide is that patients with 
abnormal cystic ducts as a cause of their symp- 
toms demonstrate a diminished gallbladder ejec- 
tion fraction. The gallbladder ejection fraction is 
calculated by determining the net count rate in 
the gallbladder before cholecystogogue adminis- 
tration and at specified time intervals thereafter. In 
Fink-Bennett and colleagues’ series, no patient 
with a pathologically confirmed abnormality of the 
cystic duct had an ejection fraction exceeding 
22% .‘27 The percentage of tracer expelled from the 
gallbladder should exceed 35% at 20 minutes in 
normal subjects. 
CENTRAL NERVOUS SYSTEM 
INTERVENTIONS 
Interventional studies of the central nervous sys- 
tem have not yet become extensively used clini- 
cally but have figured significantly in research 
aimed at understanding the relationship between 
cerebral anatomy, function, and metabolism. The 
brain has evolved so that specific anatomic regions 
in the cortex are responsible for effecting specific 
functions. As these regions are activated by physi- 
cal or cognitive stimuli, the resulting changes in 
blood flow and metabolism can be directly mea- 
sured by radionuclide techniques. The most ex- 
tensively used radiopharmaceutical for such met- 
abolic studies is ‘8F-fluorodeoxyglucose. Kinetic 
models have been developed that permit the ac- 
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tual measurement of the glycolytic rate on a per- 
gram-of-tissue basis.12g-131 The current assumption 
is that the rate of glucose utilization directly re- 
flects functional activity since it is the essential 
metabolic substrate in the brain. 
Elegant studies have been performed to map 
“cerebral activation” in response to physical stim- 
uli or cognitive paradigms.132-13” For example, a 
baseline study of regional cerebral blood flow or 
glucose metabolism may be first obtained in a 
quiet darkened room with the patient’s eyes 
closed. Cortical activation in response to visual or 
auditory stimuli or to complex scenes then per- 
mits a direct demonstration of which regions of 
the brain are processing these stimuli. 
More recently, studies of the central nervous 
system have been extended to include a vari- 
ety of receptor-binding radiopharmaceuticals.‘36’ 137 
These agents are being used to probe the status of 
receptor activity and binding capacity. Pretreat- 
ment or post-treatment with “cold” receptor-bind- 
ing drugs can significantly alter the radiotracer up- 
take patterns and may provide inferences on 
binding capacity and the relative affinity of recep- 
tors in different areas. 
CONCLUSION 
Interventional studies have several important 
broad implications for the practice of nuclear 
medicine. First, interventional studies are typically 
more complex than are noninterventional studies. 
‘I’hey involve administering potent drugs and per- 
forming physiological maneuvers that may elicit 
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significant symptoms. Physicians performing these 
types of studies must learn not only the technical 
details of the imaging procedure but the rationale 
for the interventional portion of the procedure and 
the appropriate response to complications or side 
effects that may ensue. 
Most important, the interventional concept has 
extended the diagnostic utility of the associated 
procedures. As new radiopharmaceuticals are de- 
veloped for studies of the heart and brain, it is 
highly likely that they will be employed in the con- 
text of interventions. The horizons of nuclear med- 
icine will be extended not only through the 
development of new equipment and radiophar- 
maceuticals but also through the development of 
new, creative, and imaginative interventional ma- 
neuvers. 
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